Author

ROBERTO VISENTIN

Aptuit (Italy)ORCID 0000-0002-5848-5990Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 3 Research Focus:drug response / drug discovery· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Approach:experimental assay· 1

Frequent Co-Authors

Alessia Tagliavini· 3 shared Chiara RoversiiD· 3 shared Marco Pergher· 3 shared Simone Zannoni· 3 shared Anna M. UptoniD· 2 shared Cécile PascaliD· 2 shared Clara Aguilar-PéreziD· 2 shared David J. Hermann· 2 shared

Activity by Year

2026-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersPharmacology & Toxicology

Alessia Tagliavini

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Pharmacology & ToxicologybioRxivPreprintSep 29, 2026

Impact of GPR39 Inhibition on Tissue Oxygen Tension in Acute Myocardial Infarction: Modeling Using an Indirect Response Pharmacokinetics/Pharmacodynamics Approach

Davide Ronchi, Chiara Roversi, Simone Zannoni…·Sanjiv Kaul

This paper develops a population PK/PD model to simulate the effects of VC108, a GPR39 inhibitor, on myocardial oxygen tension during acute myocardial infarction and reperfusion.

DOI 10.64898/2026.09.24.754288

mousestatistical model

𝕏 PostBluesky

Pharmacology & ToxicologybioRxivPreprintJun 23, 2026

Next Generation TB Drug Combinations from the Pan-TB Consortium: Combination Efficacy and Contributions of Individual Agents, Evaluated in a BALB/c Mouse TB Model

Sylvie Sordello, Alain Le Coupanec, Zoï Vahlas…·Anna M. Upton

The paper evaluates next-generation TB drug combinations in a mouse model, showing some regimens cure 90% of mice in under 2 months with faster sterilizing efficacy than existing treatments.

DOI 10.64898/2026.06.18.733138

mouseexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivPreprintMay 7, 2026

Nonclinical pharmacokinetics and relative efficacy of the first 25 novel tuberculosis drug combinations from the PAN-TB consortium: Use of the BALB/c relapsing mouse model and combination pharmacokinetics within a modeling-based framework

Sylvie Sordello, Alessia Tagliavini, Xavier Boulenc…·Anna M. Upton

The paper evaluates 25 tuberculosis drug combinations in a mouse model, finding 15 combinations with T90 <5 months and three top combinations curing 90% of mice in <3 months.

1 citation

mousestatistical model

𝕏 PostBluesky